Article Text
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia
Summary
Mixed warm and cold autoimmune anaemia is a rare haemolytic anaemia that is commonly associated with lymphoproliferative disorders and autoimmune diseases. Although steroid therapy is the first-line treatment, rituximab represents a good alternative. The present study reports on a successful treatment with rituximab in a young woman suffering from a mixed warm and cold autoimmune haemolytic anaemia associated with a mixed connective tissue disease.
Statistics from Altmetric.com
Footnotes
Competing interests: None.
Patient consent: Patient/guardian consent was obtained for publication.